Details

NameSymbolSector
SOLARA ACTIVE PHARMA SCIENCES LIMITEDSOLARAPharmaceuticals
Open
708
High
719
Low
683.05
Close
701.8
Volume
800696
Exchange
nse
Time
08-Sep-2026

Outlook

Score:

3

Rating:

RISKY

Candlestick Pattern

CandlepatternofSolaraActivePharmaSciencesis
Short Body
EstimatedStoplossofSolaraActivePharmaSciencesis
719
SolaraActivePharmaScienceshasa
Bearishℹ
pattern.
Formationof
Short Body
candlepatternindicatesthetrenddirectionofSolaraActivePharmaSciencesis
Unpredictableℹ
.

Trend

SolaraActivePharmaSciencesisin
Uptrendℹ
.
PriceofSolaraActivePharmaSciencesis
Upℹ
by

22.97

%.
Target
Buy@

509.1

Sell@

711

Current@

701.8

Volume

ThetradesofSolaraActivePharmaScienceshavebeenin
Immenseℹ
volume.
ThevolumetradesforSolaraActivePharmaSciencesare
Bullishℹ
with
Strong Buyersℹ
ThetradevolumeofSolaraActivePharmaSciencesis

Up

by

74.31

%

Valuation

ThecurrentmarketpriceofSolaraActivePharmaSciencesis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth2231crandtotalassetsworth2231cr,thebalancesheetofSolaraActivePharmaSciencesis:
Balancedℹ
.
Cashflow
SolaraActivePharmaScienceshas
Insufficientℹ
cashflowbecausethereis

Shortage

of

₹ 4cr

.Itis
Downℹ
by

0

%.
49.53% i.e. ₹ 212cr earned in operatingℹ
8.41% i.e. ₹ 36cr spent in investingℹ
42.06% i.e. ₹ 180cr spent in financingℹ
0% in otherℹ
SolaraActivePharmaScienceshas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Upℹ
by

100

%.
50% i.e. ₹ 108cr earned in operatingℹ
1.39% i.e. ₹ 3cr spent in investingℹ
48.61% i.e. ₹ 105cr spent in financingℹ
0% in otherℹ
Income
TheincomeofSolaraActivePharmaSciencesis

₹ 314cr

and

Loss

is:

₹ 10cr

SolaraActivePharmaSciencesLossesincreasedby:

200

%andIncomeisDownby:

1.88

%
TheincomeofSolaraActivePharmaSciencesis

₹ 320cr

and

Profit

is:

₹ 10cr

SolaraActivePharmaSciencesProfitisupby:

600

%andIncomeisUpby:

15.11

%
TheincomeofSolaraActivePharmaSciencesis

₹ 278cr

and

Loss

is:

₹ 2cr

SolaraActivePharmaSciencesLossesincreasedby:

125

%andIncomeisDownby:

7.64

%
By using this site you agree to the use of cookies to deliver a better site experience.